Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $249.5K | conv 33Cluster | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $84.3K | conv 33Cluster | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $496.9K | conv 33First in 12mo | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $5.9M | conv 47Unusual size | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $75.1K | conv 19 | SEC | |
Tricida, Inc.Listing unverified | Buy | $5.4M | conv 52ClusterUnusual size | SEC | |
Tricida, Inc.Listing unverified | Buy | $804.3K | conv 27Cluster | SEC | |
Tricida, Inc.Listing unverified | Buy | $1.7M | conv 36Cluster | SEC | |
Tricida, Inc.Listing unverified | Buy | $245.3K | conv 49ClusterFirst in 12mo | SEC | |
Tricida, Inc.Listing unverified | Buy | $327.9K | conv 33Cluster | SEC | |
Tricida, Inc.Listing unverified | Buy | $361.7K | conv 25Cluster | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Sell | $14.4M | SEC | ||
AveXis, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AveXis, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AveXis, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AveXis, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AveXis, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AveXis, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AveXis, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Oruka Therapeutics, Inc.Listing on record | Sell | $825K | SEC | ||
Oruka Therapeutics, Inc.Listing on record | Sell | $21.9K | SEC | ||
AveXis, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AveXis, Inc.Listing unverified | Buy | $2M | conv 51ClusterFirst in 12mo | SEC | |
AveXis, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
AveXis, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |